Trials / Completed
CompletedNCT00180531
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
Monitoring of Arrhythmias and Heart Rate Variability in Patients With Congestive Heart Failure Treated With the Cardiac Resynchronisation Pacemaker Renewal TR2
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (planned)
- Sponsor
- Guidant Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the prevalence of sustained ventricular and supraventricular rhythm disorders in patients implanted with a CONTAK RENEWAL TR2 ventricular resynchronization therapy (CRT) device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Renewal TR2 |
Timeline
- Start date
- 2004-02-01
- Completion
- 2007-06-01
- First posted
- 2005-09-16
- Last updated
- 2007-12-13
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00180531. Inclusion in this directory is not an endorsement.